Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Cash from Investing Activities (2020 - 2025)

Silence Therapeutics' Cash from Investing Activities history spans 6 years, with the latest figure at -$53.3 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 180.66% to -$53.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.0 million, a 133.37% decrease, with the full-year FY2025 number at -$48.0 million, down 118.48% from a year prior.
  • Cash from Investing Activities hit -$53.3 million in Q4 2025 for Silence Therapeutics, down from $51.3 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for SLN hit a ceiling of $66.1 million in Q4 2024 and a floor of -$53.3 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$2.8 million across 5 years, with a median of -$46787.5 in 2022.
  • Biggest five-year swings in Cash from Investing Activities: surged 52887.25% in 2023 and later plummeted 32177.6% in 2024.
  • Tracing SLN's Cash from Investing Activities over 5 years: stood at $6.0 million in 2021, then tumbled by 420.8% to -$19.3 million in 2022, then skyrocketed by 102.46% to $474120.0 in 2023, then soared by 13846.89% to $66.1 million in 2024, then plummeted by 180.66% to -$53.3 million in 2025.
  • Business Quant data shows Cash from Investing Activities for SLN at -$53.3 million in Q4 2025, $51.3 million in Q3 2025, and -$1.6 million in Q2 2025.